$11.13
0.14% today
Nasdaq, Apr 02, 09:19 pm CET
ISIN
US2928121043
Symbol
ENFN

Enfusion Stock price

$11.11
-0.26 2.29% 1M
+2.03 22.36% 6M
+0.81 7.86% YTD
+1.87 20.24% 1Y
-1.67 13.07% 3Y
-8.70 43.92% 5Y
-8.70 43.92% 10Y
Nasdaq, Closing price Tue, Apr 01 2025
-0.04 0.36%
ISIN
US2928121043
Symbol
ENFN

Key metrics

Market capitalization $1.05b
Enterprise Value $1.05b
P/E (TTM) P/E ratio 544.61
EV/FCF (TTM) EV/FCF 43.94
EV/Sales (TTM) EV/Sales 5.19
P/S ratio (TTM) P/S ratio 5.22
P/B ratio (TTM) P/B ratio 14.36
Revenue growth (TTM) Revenue growth 15.51%
Revenue (TTM) Revenue $201.61m
EBIT (operating result TTM) EBIT $6.16m
Free Cash Flow (TTM) Free Cash Flow $23.79m
Cash position $54.48m
EPS (TTM) EPS $0.02
P/E forward 79.36
P/S forward 4.44
EV/Sales forward 4.41
Short interest 3.57%
Show more

Is Enfusion a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Enfusion Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Enfusion forecast:

5x Hold
83%
1x Sell
17%

Analyst Opinions

6 Analysts have issued a Enfusion forecast:

Hold
83%
Sell
17%

Financial data from Enfusion

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
202 202
16% 16%
100%
- Direct Costs 65 65
13% 13%
32%
137 137
17% 17%
68%
- Selling and Administrative Expenses 95 95
33% 33%
47%
- Research and Development Expense 27 27
34% 34%
13%
16 16
40% 40%
8%
- Depreciation and Amortization 9.35 9.35
32% 32%
5%
EBIT (Operating Income) EBIT 6.16 6.16
48% 48%
3%
Net Profit 2.82 2.82
53% 53%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Enfusion directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Enfusion Stock News

Neutral
Business Wire
about 3 hours ago
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enfusion, Inc. (NYSE: ENFN) to Clearwater Analytics Holdings, Inc. (NYSE: CWAN). Under the terms of the proposed transaction, shareholders of Enfusion will receive $5.85 in cash and $5.40 in Clearwater Class A Com...
Neutral
Business Wire
30 days ago
NEW YORK & LONDON & HONG KONG--(BUSINESS WIRE)--Enfusion, Inc. ("Enfusion") (NYSE: ENFN), a leading provider of software-as-a-service (SaaS) solutions for investment managers, today announced financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Highlights: Total revenue was $52.9 million, up 13.9% compared to the same period in the prior ...
Neutral
Business Wire
about one month ago
BOISE, Idaho--(BUSINESS WIRE)--Clearwater Analytics Holdings, Inc. (NYSE: CWAN) (“Clearwater” or the “Company”), a leading worldwide provider of SaaS-based investment management, accounting, reporting, and analytics solutions, and Enfusion, Inc. (NYSE: ENFN) (“Enfusion”), a leader in software-as-a-service solutions for the investment management and hedge fund industry, today announced the expir...
More Enfusion News

Company Profile

Enfusion, Inc. engages in the development of cloud-native multi-tenant software for alternative and institutional investment managers. It is a software-as-a-service firm that develops platform to eliminate technology and information barriers, and simplify investment and operational workflows by unifying mission-critical systems and coalescing data into a single dataset. The company was founded in 2006 and is headquartered in Chicago, IL.

Head office United States
CEO Oleg Movchan
Employees 1,143
Founded 2006
Website enfusion.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today